The latest research has found that through the low-cost and reliable plastic chip blood test technology, the results of traditional invasive biopsy can be obtained. After the new chip blood test is improved, the effectiveness and accuracy can be improved. Cancer treatment and promotion to the suburban areas lacking clinical cancer screening equipment for the benefit of the majority of patients in need.
It has been reported that a malignant tumor called "MulTIple Myeloma" affects human plasma cells. Traditionally, patients need surgery, and the doctor inserts a needle into the skin incision and removes the tumor cell sample from the bone marrow. Find out how to cure, but this type of method is a waste of time.
A research team led by Steven Soper, a professor of chemical and mechanical engineering at the University of Kansas in the United States, after 10 years of research into cancer testing techniques, found that blood tests were performed on credit card-sized plastic chips, and the results obtained were not only cheap. And the reliability is high. The multiple myeloma was examined by blood sampling, and the information obtained from the microarray diagnosis was identical to that obtained from the bone marrow section.
Previously, plastic chips that detect multiple myeloma have their drawbacks, such as sampling only normal blood cells, rather than multiple myeloma cells, during blood draw. After the improvement of the efficacy and accuracy of the new chip blood test, only a small amount of blood containing myeloma cells can be diagnosed and the most effective course of treatment can be diagnosed through a sharp chip test when the early condition is still controllable.
New plastic chips are cheaper because they can be manufactured by injection molding. Just like CDs and DVDs, clinicians can determine the stage of disease development, open the most appropriate drugs and monitor the signs of recurrence after the disease is relieved. Patients only need to take blood at the time of presentation, and are also suitable for a wide range of cancer prevention and treatment tests such as blood cancer, pancreatic cancer, prostate cancer, ovarian cancer, rectal cancer and breast cancer.
Soper said that the new chip inspection technology will be introduced into the market by the cooperative BioFluidica company, the premise is to find the tumor cells through the blood test of the chip, observe the signs of disease recurrence, and simplify the test, and hope to pass more customers. The chemotherapy process is used to improve the patient's condition, and the diagnosis is confirmed before the appearance of the obvious cancer, and the survival rate of the patient is improved.
This kind of microfluidics technology is also very suitable for promotion to the rural areas where there is no high-order clinical cancer screening equipment. The future vision is to expand and promote the routine and to test the normal blood test before the onset of cancer symptoms. Early prevention.
Copper Lugs,Copper Cable Lugs,Plating Copper Cable Lugs,Copper Tube Terminal Lugs
Taixing Longyi Terminals Co.,Ltd. , https://www.longyiterminals.com